Ran‐Ju Kim

640 total citations
11 papers, 534 citations indexed

About

Ran‐Ju Kim is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Ran‐Ju Kim has authored 11 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Ran‐Ju Kim's work include Cancer Cells and Metastasis (9 papers), Cancer-related Molecular Pathways (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Ran‐Ju Kim is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer-related Molecular Pathways (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Ran‐Ju Kim collaborates with scholars based in South Korea, United States and India. Ran‐Ju Kim's co-authors include Jeong‐Seok Nam, Soo‐Rim Kim, In‐Sun Hong, Gyu-Beom Jang, Eun Sook Lee, Hwa‐Yong Lee, Gu Kong, Kyung‐Sun Kang, Yoo‐Kyung Lee and Pyeung-Hyeun Kim and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Journal of Hepatology.

In The Last Decade

Ran‐Ju Kim

11 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ran‐Ju Kim South Korea	10	368	293	159	43	38	11	534
Han-Sui Hsu Taiwan	2	365 1.0×	356 1.2×	169 1.1×	46 1.1×	29 0.8×	2	546
Erika López‐Arribillaga Spain	8	443 1.2×	309 1.1×	173 1.1×	37 0.9×	53 1.4×	8	612
Kepa Elorriaga Spain	3	329 0.9×	267 0.9×	140 0.9×	34 0.8×	27 0.7×	8	456
Valery Adorno-Cruz United States	6	324 0.9×	208 0.7×	205 1.3×	59 1.4×	45 1.2×	6	513
Deepika Neelakantan United States	9	298 0.8×	186 0.6×	180 1.1×	56 1.3×	34 0.9×	11	463
Lianne Gibson Canada	5	470 1.3×	304 1.0×	180 1.1×	40 0.9×	46 1.2×	5	647
Jiadong Chi China	12	425 1.2×	193 0.7×	267 1.7×	73 1.7×	45 1.2×	27	567
Yanqiu Zhao China	13	461 1.3×	175 0.6×	163 1.0×	48 1.1×	40 1.1×	17	651
Hildegonda P. H. Naber Netherlands	6	270 0.7×	192 0.7×	92 0.6×	28 0.7×	40 1.1×	6	419
Hemanth J. Varghese Canada	7	208 0.6×	276 0.9×	162 1.0×	60 1.4×	29 0.8×	8	458

Countries citing papers authored by Ran‐Ju Kim

Since Specialization

Citations

This map shows the geographic impact of Ran‐Ju Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran‐Ju Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran‐Ju Kim more than expected).

Fields of papers citing papers by Ran‐Ju Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran‐Ju Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran‐Ju Kim. The network helps show where Ran‐Ju Kim may publish in the future.

Co-authorship network of co-authors of Ran‐Ju Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ran‐Ju Kim. A scholar is included among the top collaborators of Ran‐Ju Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran‐Ju Kim. Ran‐Ju Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Jang, Gyu-Beom, In‐Sun Hong, Ran‐Ju Kim, et al.. (2015). Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells. Cancer Research. 75(8). 1691–1702. 145 indexed citations

Bae, Eunjin, Misako Sato, Ran‐Ju Kim, et al.. (2014). Definition of Smad3 Phosphorylation Events That Affect Malignant and Metastatic Behaviors in Breast Cancer Cells. Cancer Research. 74(21). 6139–6149. 29 indexed citations

Kim, Ran‐Ju, Eunjin Bae, Young Kwon Hong, et al.. (2014). PTEN Loss-Mediated Akt Activation Increases the Properties of Cancer Stem-Like Cell Populations in Prostate Cancer. Oncology. 87(5). 270–279. 18 indexed citations

Lee, Yoo‐Kyung, et al.. (2012). Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation. Cancer Science. 103(7). 1280–1289. 30 indexed citations

Kim, Ran‐Ju, et al.. (2012). Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer. Biochemical and Biophysical Research Communications. 425(2). 436–442. 25 indexed citations

Kim, Ran‐Ju, Soo‐Rim Kim, Pyeung-Hyeun Kim, et al.. (2012). High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. Cancer Letters. 333(1). 18–31. 77 indexed citations

Kim, Ran‐Ju, et al.. (2011). Inhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line. Laboratory Animal Research. 27(4). 333–333. 26 indexed citations

Kim, Ran‐Ju & Jeong‐Seok Nam. (2011). OCT4 Expression Enhances Features of Cancer Stem Cells in a Mouse Model of Breast Cancer. Laboratory Animal Research. 27(2). 147–147. 128 indexed citations

Kim, Ran‐Ju, Yoo‐Kyung Lee, Soo‐Rim Kim, et al.. (2010). Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells. Journal of Hepatology. 54(1). 122–131. 25 indexed citations

10.

Kim, Ran‐Ju, Soo‐Rim Kim, Sang‐Bum Park, et al.. (2009). Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer. Cancer Letters. 287(2). 172–181. 30 indexed citations

11.

Lee, Dae‐Yeol, et al.. (1994). Alteration of Serum Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) in Pregnancy: Pregnancy Associated IGFBP-3 Protease Activity. Molecules and Cells. 4(3). 321–326. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact